Molecular Targets in Cancer Therapy - Fourth Biennial Meeting. Mechanism and therapeutic reversal of immune suppression in cancer
Herber, D.L.
IDrugs the investigational drugs journal 10(4): 227-229
2007
ISSN/ISBN: 1369-7056 PMID: 17390239 Document Number: 605237
Document emailed within 1 workday
Related Documents
McKinnon, C. 1998: American Society of Clinical Oncology--34th Annual Meeting. Treatments for prostate cancer and new molecular targets. 16-19 May 1998, Los Angeles, California, USA IDrugs: the investigational drugs journal 1(2): 163-167Mitsudomi, T. 2002: Molecular lesions as targets for diagnosis and therapy of lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(Suppl 1): 112-116
Bosch, F.X.; Dürst, M.; Schwarz, E.; Boukamp, P.; Fusenig, N.E.; zur Hausen, H. 1991: The early genes E6 and E7 of cancer associated human papilloma viruses as targets of tumor suppression? Behring Institute Mitteilungen 89: 108-121
El-Deiry, W. 2000: AACR - 91st meeting. Novel concepts and targets for therapeutic manipulation IDrugs: the investigational drugs journal 3(7): 717-718
Effendi-Ys, R. 2017: Cancer Stem Cells and Molecular Biology Test in Colorectal Cancer: Therapeutic Implications Acta Medica Indonesiana 49(4): 351-359
Scholl, S.M. 2001: Molecular targets and cancer therapeutics: discovery, biology and clinical applications Idrugs: the Investigational Drugs Journal 4(12): 1357-1360
Garvey, R. 2006: AACR-NCI-EORTC--17th Symposium: Molecular Targets and Cancer Therapeutics IDrugs: the investigational drugs journal 9(2): 90-92
Maiese, K. 2013: Therapeutic targets for cancer: current concepts with Pi 3-K, Akt, and mTOR Indian Journal of Medical Research 137(2): 243-246
Ariazi, E.A.; Ariazi, J.L.; Cordera, F.; Jordan, V.C. 2006: Estrogen receptors as therapeutic targets in breast cancer Current Topics in Medicinal Chemistry 6(3): 181-202
Collins, T. 2007: AACR-NCI-EORTC--19th symposium. Molecular Targets and Cancer Therapeutics--Part 3 IDrugs: the investigational drugs journal 10(12): 840-843
Dormoy, Vérian.; Jacqmin, D.; Lang, Hé.; Massfelder, T. 2012: From development to cancer: lessons from the kidney to uncover new therapeutic targets Anticancer Research 32(9): 3609-3617
Ashok, B.T.; Chen, Y.G.; Liu, X.; Garikapaty, V.P.S.; Seplowitz, R.; Tschorn, J.; Roy, K.; Mittelman, A.; Tiwari, R.K. 2002: Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 11 Suppl. 2: S86-S93
Bishr, M.; Lattouf, J.B.; Gannon, P.O.; Saad, F. 2011: Updates on therapeutic targets and agents in castration-resistant prostate cancer Minerva Urologica e Nefrologica 63(2): 131-143
Koivisto, P.; Kononen, J.; Palmberg, C.; Tammela, T.; Hyytinen, E.; Isola, J.; Trapman, J.; Cleutjens, K.; Noordzij, A.; Visakorpi, T.; Kallioniemi, O.P. 1997: Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer Cancer Research 57(2): 314-319
Noonan, F.P.; Bucana, C.; Sauder, D.N.; De Fabo, E.C. 1984: Mechanism of systemic immune suppression by UV irradiation in vivo. II. the UV effects on number and morphology of epidermal Langerhans cells and the UV-induced suppression of contact hypersensitivity have different wavelength dependencies Journal of Immunology 132(5): 2408-2416
Veryard, C. 2006: AACR-NCI-EORTC--17th symposium: Molecular targets and cancer therapeutics. 14-18th November 2005, Philadelphia, PA, USA IDrugs: the investigational drugs journal 9(1): 1-3
McGowran, M. 2001: American Society of Gene Therapy - Fourth Annual Meeting. 30 May-3 June 2001, Seattle, WA, USA IDrugs: the investigational drugs journal 4(8): 896-900
Bogyo, D.; Mihich, E. 1980: Reversal of the in vitro methotrexate suppression of cell-mediated immune response by folinic acid and thymidine plus hypoxanthine Cancer Research 40(3): 650-654
Hoff, P.M. 2007: Novel agents and targets for the therapy of advanced colon cancer Clinical Advances in Hematology and Oncology: H&o 5(5): 365-366
Boulikas, T. 1997: Gene therapy of prostate cancer: p53, suicidal genes, and other targets Anticancer Research 17(3a): 1471-1505